Quote:

---

After publication, Sorrento’s stock shot up. Its price per share went from $2.62 at market close on Thursday to $9.96 at market open on Monday, before sliding down to a $5.23 as of Tuesday morning, a valuation that nonetheless had the company worth a tick over $1 billion. There was just one problem: The company had not put their drug in a mouse, let alone a patient.

.....Ethicists were particularly concerned about Ji’s interview with Fox News, in which he not only said there was a cure but appeared to imply that, because of it, people can avoid the social distancing practices that experts say have helped stem the virus’s spread.

---